Engagement will assess KALA’s clinical assets, development options, and AI-enabled analytical opportunities, including the ...
MEDIA ALERT]Flagship's early-stage companies to receive AWS cloud credits, technical support, and AI capabilities to ...
Chemicals company Evonik is realigning its strategic research unit. The Evonik Innovation Factory operates as an ...
Selection Follows Positive Phase 3 Results for Paridiprubart Demonstrating Statistically Significant Mortality Reductions in ...
Preview this article 1 min Biogen is buying a Boston-area biotech that already has two approved drugs to drive short-term and ...
CALGARY, AB, March 31, 2026 /CNW/ - Genome Alberta, with support from the Government of Alberta, is pleased to announce five ...
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the ...
Giant kelp forests once defined much of San Diego’s coastline: towering marine canopies that shelter fish populations, buffer ...
The UK must tackle commercial, funding and systemic challenges to fully harness its global life sciences, pharma and biotech potential.
Amicus Brief Addresses PTAB Review of Obviousness-Type Double Patenting and Patent Term Issues Affecting Biotech ...
Newcastle University and Procter & Gamble (P&G) are marking over 10 years of partnership with a new report showcasing their shared achievements and future goals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results